Research and Development

Home » Research and Development

New Research Hub Tackles the Spread of New Diseases

The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, has announced its involvement in the development of a new research hub aimed at delivering high-quality vaccines at low cost, with aims of preventing outbreaks of diseases such as Zika and Ebola. The new Future Vaccine Manufacturing Hub is being led [...]

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Under a new contract, Cambridge Research Biochemicals will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision. Cambridge Research Biochemicals (CRB), under contract to Leidos Biomedical Research, Inc., will develop reagents to evaluate eFGF-1, a compound that can promote repair [...]

Industry Partnerships Inspired by University Life Sciences Showcase

The University of Leicester has kick-started a trailblazing programme to drive engagement between academia and life sciences companies. The pioneering, 18-month, Industry & Academia Exchange (IAX) programme funded through the Medical Research Council’s Proximity to Discovery Scheme, got under way with an inspiring showcase event at Winstanley House in Leicester. The one-day IAX showcase brought [...]

New Project to Enhance Nanomedicine Development

The Centre for Process Innovation (CPI), a UK-based technology innovation provider for process manufacturing, has launched a new collaborative project that strengthens its nanoformulation capabilities to better develop next-generation nanomedicines. The project aims to evaluate a new microfluidic-based platform for the scale-up, process development and manufacture of nanoformulated medicines. If successful, CPI will make the [...]

WuXi STA to Build New R&D Centre in Shanghai

STA Pharmaceutical Co., Ltd, a subsidiary of WuXi AppTec (WuXi STA), announces that it has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D centre. The new facility will further strengthen WuXi STA’s global leading pharmaceutical development and manufacturing platform, enabling drug developers to accelerate their projects from [...]

Sartorius Stedim Biotech and Penn State University Announce Partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to enhance the Fermentation Facility that will play a significant role in [...]

Owlstone Medical Provides Breath Biopsy Services to AstraZeneca to Study Disease Drivers in Asthma and COPD

Owlstone Medical, a diagnostics company developing a breathalyser for disease, has signed a service agreement with AstraZeneca plc, a global biopharmaceutical company. The collaboration will explore how breath can be used to identify novel biomarkers to help differentiate between disease phenotypes relevant for asthma and COPD. Owlstone Medical will provide AstraZeneca with access to its [...]

Antiepileptic Drugs Increase Risk of Alzheimer’s and Dementia

The use of antiepileptic drugs is associated with an increased risk of Alzheimer’s disease and dementia, according to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE. Continuous use of antiepileptic drugs for a period exceeding one year was associated with a 15% increased risk of Alzheimer’s [...]

Quay Takes Lead in Live Biotherapeutics

Pharmaceutical outsourcing specialist Quay Pharma is continuing to invest in its pioneering work in live biotherapeutics with the establishment of specialist GMP suites at its facility in Deeside, Flintshire. Quay’s longstanding experience has already seen it become the first UK contracting company to bring live bacteria into a finished product, and it is one of [...]

The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the Lab of the Future

The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling upon the industry to support the Lab of the Future (LoTF) through greater collaboration. At The Pistoia Alliance’s annual EU member conference in London, President of the Pistoia Alliance, Dr Steve Arlington, urged [...]